Thrivent Financial for Lutherans Has $4.95 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

Thrivent Financial for Lutherans decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,743 shares of the medical device company’s stock after selling 1,993 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Cooper Companies were worth $4,953,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Sei Investments Co. boosted its holdings in shares of Cooper Companies by 15.6% during the second quarter. Sei Investments Co. now owns 266,841 shares of the medical device company’s stock worth $23,296,000 after acquiring an additional 36,039 shares during the period. Pacer Advisors Inc. lifted its holdings in Cooper Companies by 28.5% during the 2nd quarter. Pacer Advisors Inc. now owns 17,465 shares of the medical device company’s stock worth $1,525,000 after purchasing an additional 3,870 shares during the last quarter. Canada Pension Plan Investment Board boosted its stake in Cooper Companies by 12.1% in the 2nd quarter. Canada Pension Plan Investment Board now owns 233,974 shares of the medical device company’s stock valued at $20,426,000 after purchasing an additional 25,238 shares during the period. Ieq Capital LLC grew its holdings in Cooper Companies by 5.6% in the 2nd quarter. Ieq Capital LLC now owns 22,809 shares of the medical device company’s stock valued at $1,991,000 after buying an additional 1,213 shares in the last quarter. Finally, Intech Investment Management LLC increased its position in Cooper Companies by 301.9% during the 2nd quarter. Intech Investment Management LLC now owns 39,697 shares of the medical device company’s stock worth $3,466,000 after buying an additional 29,819 shares during the period. 24.39% of the stock is owned by institutional investors.

Cooper Companies Price Performance

Shares of COO stock opened at $109.78 on Friday. The business has a fifty day simple moving average of $99.84 and a 200 day simple moving average of $95.81. The company has a market cap of $21.86 billion, a P/E ratio of 64.58, a P/E/G ratio of 2.63 and a beta of 0.98. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.84 earnings per share. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In other news, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares of the company’s stock, valued at $700,422.60. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock worth $27,637,427 over the last quarter. Corporate insiders own 2.00% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on COO. Robert W. Baird boosted their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Morgan Stanley lifted their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Piper Sandler increased their price target on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Finally, Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and raised their price objective for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $115.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.